HUTCHMED (LON:HCM) Stock Passes Below 200-Day Moving Average of $260.57

HUTCHMED (China) Limited (LON:HCMGet Free Report)’s share price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 260.57 ($3.27) and traded as low as GBX 212 ($2.66). HUTCHMED shares last traded at GBX 218 ($2.73), with a volume of 99,512 shares changing hands.

HUTCHMED Stock Performance

The company has a market cap of £1.98 billion, a PE ratio of -5,450.00 and a beta of 0.62. The firm’s fifty day moving average is GBX 257.14 and its 200 day moving average is GBX 260.57. The company has a current ratio of 3.20, a quick ratio of 2.97 and a debt-to-equity ratio of 5.02.

About HUTCHMED

(Get Free Report)

HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in Hong Kong and internationally. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and renal cell carcinoma, colorectal cancer (CRC), and gastric cancer (GC); and Fruquintinib, an inhibitor for CRC, breast cancer, GC, endometrial cancer (EMC), NSCLC, hepatocellular carcinoma, and gastrointestinal and solid tumors.

Featured Stories

Receive News & Ratings for HUTCHMED Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HUTCHMED and related companies with MarketBeat.com's FREE daily email newsletter.